| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/04/2004 | WO2004018648A2 Methods for treating patients and identifying therapeutics |
| 03/04/2004 | WO2004018598A1 Fat composition |
| 03/04/2004 | WO2004018491A1 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 03/04/2004 | WO2004018484A1 Beta-lactamase inhibitor prodrug |
| 03/04/2004 | WO2004018483A1 Fused heterocyclic isoxazoline derivatives and their use as anti-depressants |
| 03/04/2004 | WO2004018482A2 C6- and c9-substituted chromeno[4, 3-c]isoxazoline derivatives and their use as anti-depressants |
| 03/04/2004 | WO2004018479A1 Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone |
| 03/04/2004 | WO2004018476A1 Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
| 03/04/2004 | WO2004018472A2 Pyrimido compounds having antiproliferative activity |
| 03/04/2004 | WO2004018465A2 Benzonaphthyridines with pde 3/4 inhibiting activity |
| 03/04/2004 | WO2004018459A1 Pyrazole derivatives as gnrh inhibitors |
| 03/04/2004 | WO2004018458A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 03/04/2004 | WO2004018457A1 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
| 03/04/2004 | WO2004018453A1 Proline derivatives |
| 03/04/2004 | WO2004018451A1 Pyridazinone-derivatives as pde4 inhibitors |
| 03/04/2004 | WO2004018450A1 Piperidine-n-oxide-derivatives |
| 03/04/2004 | WO2004018448A1 Novel thiophene derivatives, preparation method thereof and pharmaceutical compositions containing same |
| 03/04/2004 | WO2004018444A1 Clathrates of butylphtualide with cyclodextrin or its derivatives, a process for their preparations and the use there of |
| 03/04/2004 | WO2004018442A1 Crystalline and amorphous forms of (s) -repaglinide and the processes for preparation thereof |
| 03/04/2004 | WO2004018439A1 Novel antibacterial agents |
| 03/04/2004 | WO2004018434A1 Pyrimidine compounds |
| 03/04/2004 | WO2004018431A2 Novel phenanthridines |
| 03/04/2004 | WO2004018426A1 Organic acid salt of amlodipine |
| 03/04/2004 | WO2004018425A1 N-4-piperidinyl compounds as ccr5 modulators |
| 03/04/2004 | WO2004018422A1 Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists |
| 03/04/2004 | WO2004018419A2 Benzimidazole quinolinones and uses thereof |
| 03/04/2004 | WO2004018417A1 An improved process for the preparation of xanthophyll crystals |
| 03/04/2004 | WO2004018414A2 Antibacterial agents |
| 03/04/2004 | WO2004018412A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 03/04/2004 | WO2004018411A1 Muscarinic agonists |
| 03/04/2004 | WO2004018409A1 An improved process for the synthesis of (±) 2-amino-n-[2,(s,5-dimethoxyphenyl)-2-hydroxyethyl] acetamide monohydrochloride |
| 03/04/2004 | WO2004018407A1 Crystal of amino acid ester salt and process for producing the same |
| 03/04/2004 | WO2004018386A2 Acetophenone potentiators of metabotropic glutamate receptors |
| 03/04/2004 | WO2004018058A2 Compounds, compositions, and methods |
| 03/04/2004 | WO2004018044A2 N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyridine-3 sulphonamide as an anticancer agent |
| 03/04/2004 | WO2004018043A1 A pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease |
| 03/04/2004 | WO2004018042A2 Use of antisense oligonucleotides for treating degenerative skin symptoms |
| 03/04/2004 | WO2004018041A1 Use of a ppar-alpha agonist to treat weight gain associated with a ppar-gamma agonist treatment |
| 03/04/2004 | WO2004018025A1 Pharmaceutical compositions |
| 03/04/2004 | WO2004018010A2 Methods of drug delivery using sulphated chitinous polymers |
| 03/04/2004 | WO2004018000A2 Compositions and methods for treating cancer using maytansinoid cd44 antibody immonoconjugates and chemotherapeutic agents |
| 03/04/2004 | WO2004017998A2 Topical emulsion- gel composition comprising diclofenac sodium |
| 03/04/2004 | WO2004017997A1 Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 03/04/2004 | WO2004017996A1 Arthrodial cartilage extracellular matrix degradation inhibitor |
| 03/04/2004 | WO2004017995A1 Preventive and/or therapeutic drugs for itch |
| 03/04/2004 | WO2004017994A1 Preventive and/or therapeutic drugs for asthma |
| 03/04/2004 | WO2004017993A1 Combination of prostacyclin or prostacyclin analogues and endothelin receptor antagonists for the treatment of pulmonary arterial hypertension |
| 03/04/2004 | WO2004017989A1 Methods for improving islet signaling in diabetes mellitus and for its prevention |
| 03/04/2004 | WO2004017984A1 Method for cancer therapy using herbal extracts |
| 03/04/2004 | WO2004017981A1 Extraction method for effectively obtaining amygdalin from persicae semen or armeniacae semen |
| 03/04/2004 | WO2004017979A2 Medicament, food supplement, and fodder additive |
| 03/04/2004 | WO2004017975A1 Stable aqueous solutions of risperidone and methods for their preparation |
| 03/04/2004 | WO2004017974A1 Piperidine-pyridazones and phthalazones as pde4 inhibitors |
| 03/04/2004 | WO2004017973A1 Remedy for integration dysfunction syndrome |
| 03/04/2004 | WO2004017972A1 Biologic skin repair and enhancement |
| 03/04/2004 | WO2004017971A1 Use of a papaverine-like vasodilator and pharmaceutical composition |
| 03/04/2004 | WO2004017970A1 Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders |
| 03/04/2004 | WO2004017969A1 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
| 03/04/2004 | WO2004017967A1 Multifunctional cox-2 inhibitors |
| 03/04/2004 | WO2004017966A1 Five-membered heterocyclic compounds in the treatment of chronic and acute pain |
| 03/04/2004 | WO2004017965A1 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain |
| 03/04/2004 | WO2004017964A1 Combination therapy for hyperproliferative diseases |
| 03/04/2004 | WO2004017963A1 Benzimidazole derivatives |
| 03/04/2004 | WO2004017962A2 Tropical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region |
| 03/04/2004 | WO2004017961A2 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 03/04/2004 | WO2004017960A1 Treatment of lower urinary tract symptoms associated with overactive bladder in men and women |
| 03/04/2004 | WO2004017959A2 Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin |
| 03/04/2004 | WO2004017958A1 Soft capsule preparation |
| 03/04/2004 | WO2004017957A1 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 03/04/2004 | WO2004017956A1 Dosage forms and related therapies |
| 03/04/2004 | WO2004017955A1 L-arginine containing pharmaceutical composition |
| 03/04/2004 | WO2004017954A1 Agent for reducing side effects of diclofenac |
| 03/04/2004 | WO2004017953A1 Preventive therapeutic composition for muscular fatigue, pulled muscle and disease attributed thereto |
| 03/04/2004 | WO2004017952A1 Method of treating osteoarthritis |
| 03/04/2004 | WO2004017951A1 Use of bupropion for the manufacture of a medicament for treating restless legs syndrome |
| 03/04/2004 | WO2004017950A2 Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents |
| 03/04/2004 | WO2004017949A2 Prophylaxis and treatment of infectious diseases |
| 03/04/2004 | WO2004017948A2 Use of lck inhibitor for treatment of immunologic diseases |
| 03/04/2004 | WO2004017944A1 Liposomal gemcitabine compositions for better drug delivery |
| 03/04/2004 | WO2004017943A2 Non-vesicular cationic lipid formulations |
| 03/04/2004 | WO2004017942A1 Inhalation compositions with high drug ratios |
| 03/04/2004 | WO2004017941A2 Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist |
| 03/04/2004 | WO2004017940A2 Pharmaceutically active lipid based formulation of sn38 |
| 03/04/2004 | WO2004017939A1 Medical instrument to be implanted in the body |
| 03/04/2004 | WO2004017938A2 Nitrofurantoin controlled release dosage form |
| 03/04/2004 | WO2004017937A1 Biodegradable composition with prolonged release of the biological active compound and preparation thereof |
| 03/04/2004 | WO2004017925A2 Methods and reagents for preventing bacteremias |
| 03/04/2004 | WO2004017924A2 Methods of treating involuntary facial spasms and facial wrinkles |
| 03/04/2004 | WO2004017922A2 Keto cannabinoids with therapeutic indications |
| 03/04/2004 | WO2004017920A2 Novel biphenyl and biphenyl-like cannabinoids |
| 03/04/2004 | WO2004017918A2 Method of preparing dry powder inhalation compositions |
| 03/04/2004 | WO2004017917A2 Method for the prevention and/or treatment of atherosclerosis |
| 03/04/2004 | WO2004017916A2 Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition |
| 03/04/2004 | WO2004017914A2 Inhalation composition |
| 03/04/2004 | WO2004017913A2 Arginine silicate inositol complex and use thereof |
| 03/04/2004 | WO2004017908A2 Calcium receptor modulating compound and use thereof |
| 03/04/2004 | WO2004017906A2 Modulation of matrix metalloproteinase (mmp) activity with aldosterone blocker(s) |
| 03/04/2004 | WO2004017904A2 Corticosteroid conjugates and uses thereof |
| 03/04/2004 | WO2004017903A2 Methods for treating fungal infections |
| 03/04/2004 | WO2004017897A2 Aripiprazole complex formulation and method |